Pneumonia in the ICU: A lethal or VAPid complication?

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 10, 2011, Pages 1097-1098

  Scales, Damon C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; EDITORIAL; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MORTALITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VENTILATOR ASSOCIATED PNEUMONIA;

FEMALE; HUMANS; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 81455128878     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201109-1589ED     Document Type: Editorial

References (14)

1. Legras A, Malvy D, Quinioux AI, Villers D, Bouachour G, Robert R, Thomas R. Nosocomial infections: prospective survey of incidence in five French intensive care units. Intensive Care Med 1998;24:1040-1046. (Pubitemid 28497821)
2. Flanagan ME, Welsh CA, Kiess C, Hoke S, Doebbeling BN; Agency for Heathcare Research and Quality (AHRQ) Hospital-Acquired Infections (HAI) Collaborative. A national collaborative for reducing health care-associated infections: current initiatives, challenges, and opportunities. Am J Infect Control (In press)
3. Ontario Ministry of Health and Long-term Care. Ventilator associated pneumonia [Accessed September 1, 2011]. Available from: http://www.health.gov. on.ca/patient-safety/public/vap/vap-pub.html.
4. Muscedere J, Dodek P, Keenan S, Fowler R, Cook D, Heyland D, Guidelines VAP Committee and the Canadian Critical Care Trials Group. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention. J Crit Care 2008;23:126-137. (Pubitemid 351400352)
5. Melsen WG, Rovers MM, Bonten MJM. Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med 2009;37:2709-2718.
6. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:2184-2193.
7. Klompas M, Platt R. Ventilator-associated pneumonia: the wrong quality measure for benchmarking. Ann Intern Med 2007;147:803-805. (Pubitemid 351664444)
8. Klompas M. Does this patient have ventilator-associated pneumonia? JAMA 2007;297:1583-1593. (Pubitemid 46588372)
9. Melsen WG, Rovers MM, Koeman M, Bonten MJ. Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies. Crit Care Med (In press)
10. Bekaert M, Timsit JF, Vansteelandt S, Depuydt P, Vésin A, Garrouste-Orgeas M, Decruyenaere J, Clec'h C, Azoulay E, Benoit D. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 2011;184:1133-1139.
11. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000;11:550-560. (Pubitemid 30660034)
12. Shorr AF, Zilberberg MD, Kollef M. Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2009;30:759-763.
13. van Nieuwenhoven CA, Buskens E, Bergmans DC, van Tiel FH, Ramsay G, Bonten MJ. Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care units. Crit Care Med 2004;32:126-130. (Pubitemid 38125573)
14. Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, Cohen MM, Fraser VJ. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:1312-1317. (Pubitemid 36583837)